Triazole compounds that modulate Hsp90 activity

Details Triazole compounds that modulate Hsp90 activity Triazole compounds that modulate Hsp90 activity

2007-05-25

2011-11-08

Chu, Yong (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S263200

Reexamination Certificate

active

08053456

ABSTRACT:
The present invention relates to substituted triazole compounds and compositions comprising substituted triazole compounds. The invention further relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for preventing or treating hyperproliferative disorders, such as cancer, in a subject in need thereof comprising administering to the subject a substituted triazole compound of the invention, or a composition comprising such a compound.

REFERENCES:
patent: 3189614 (1965-06-01), Pesson
patent: 4269846 (1981-05-01), Huang et al.
patent: 4624995 (1986-11-01), Katritzky et al.
patent: 4740568 (1988-04-01), Katritzky et al.
patent: 4931084 (1990-06-01), Findeisen et al.
patent: 5006650 (1991-04-01), Barbachyn
patent: 5298520 (1994-03-01), Baker et al.
patent: 5371101 (1994-12-01), Itoh et al.
patent: 5395818 (1995-03-01), Haas et al.
patent: 5436252 (1995-07-01), Sorensen et al.
patent: 5464810 (1995-11-01), Haas et al.
patent: 5466820 (1995-11-01), Itoh et al.
patent: 5476946 (1995-12-01), Linker et al.
patent: 5489598 (1996-02-01), Connor et al.
patent: 5510362 (1996-04-01), Matassa et al.
patent: 5538988 (1996-07-01), Martinez et al.
patent: 5663362 (1997-09-01), Haas et al.
patent: 5869509 (1999-02-01), Romine et al.
patent: 5888694 (1999-03-01), Yamada et al.
patent: 5952502 (1999-09-01), McCullough et al.
patent: 6077861 (2000-06-01), Romine et al.
patent: 6194090 (2001-02-01), Okada
patent: 6258957 (2001-07-01), Linker et al.
patent: 6271249 (2001-08-01), Romine et al.
patent: 6492406 (2002-12-01), Karabelas et al.
patent: 6583090 (2003-06-01), Gewehr et al.
patent: 2005/0058956 (2005-03-01), Watanabe et al.
patent: 2005/0288347 (2005-12-01), Hodge et al.
patent: 2 546 887 (1983-05-01), None
patent: 59010574 (1984-01-01), None
patent: 2000284412 (2000-10-01), None
patent: 2003114488 (2003-04-01), None
patent: WO 98/04135 (1998-02-01), None
patent: WO 03/055860 (2003-07-01), None
patent: WO 2005/000300 (2005-01-01), None
patent: WO 2005/044194 (2005-05-01), None
patent: WO 2006/055760 (2006-05-01), None
patent: WO 2006/087077 (2006-08-01), None
patent: WO 2006/095783 (2006-09-01), None
patent: WO 2007/094819 (2007-08-01), None
Byrn et al. Solid-State Chemistry of Drugs, 2d, Chapter 11 Hydrates and Solvates, 233-247 (1999).
Morissette et al. Adv. Drug Delivery Rev. 56:275 (2004).
Rouhi, Chem. & Eng. News, Feb. 24, 2003, 81(8), 32-35.
Ciugureanu, C., et al., “Studial Activitÿÿii Biologice a unor noi Tiosemicarbazide ÿi a Derivaÿilor Acestora cu Nucleu Triazolic ÿi Tiadiazolic III. Testarea Activitÿÿii Antimicrobiene,”Farmacia, XXX(1): 57-64 (1982).
Ciugureanu, C., et al., “Studial Activitÿÿii Biologice a unor noi Tiosemicarbazide ÿi a Derivaÿilor Acestora cu Nucleu Triazolic ÿi Tiadiazolic IV. Testarea Activitÿÿii Citostatice,” Farmacia, XXX(2): 101-110 (1982).
Yuksek, Haydar and Ikizler A. A., “Synthesis of 4-Succinimido-4,5-Dihydro-1H-1,2,4-Triazol-5-ones,”Turkish Journal of Chemistry, 18: 57-61 (1994).
Maliszewska, A., “The Reaction of N3-Substituted Amidrazones with Urea,” Annales Universitatis Mariae Curie-Sklodowska Lublin-Polonia, vol. XLI, 5, Sectio AA:63-67 (1986).
Grashey, R., et al., “Zur Synthese Mesoionischer 1,2,4-Triazol-3-Thione,”Tetrahedron Letters 29: 2939-2942 (1972).
Goswami, B.N., et al., “Synthesis and Antibacterial Activity of 1-(2,4-Dichlorobenzoyl)-4-Substituted Thiosemicarbazides, 1,2,4-Triazoles and Their Methyl Derivatives,”Journal of Heterocyclic Chemistry 21(4): 1225-1229 (Jul.-Aug. 1984).
Goswami, B.N., et al., “Synthesis and Antifungal Activities of Some New Substituted 1,2,4-Triazoles and Related Compounds,”Journal of the Indian Chemical Society LXI(6): 471-564 (1984).
Malbec, F., et al., “Dérivés de la Dihydro-2,4 Triazole-1,2,4 Thione-3 et de l-amino-2 Thiadiazole-1,3,4 a Partir de Nouvelles Thiosemicarbazones d'esters,”Journal of Heterocyclic Chemistry 21(6): 1689-1698 (Nov.-Dec. 1984).
Coburn, M.D., et al., “Picrylamino-Substituted Heterocycles III. 1,2,4,-Triazoles (1,2),”Journal of Heterocyclic Chemistry 5(2): 199-203 (Apr. 1968).
Eckstein, M., et al., “The Aminoxides of Physiologically Active Compounds,”Department of Pharmaceutical Chemistry, Academy of Medicine, Cracow: 197-204, Diss. Pharm., 9 (1957).
Potts, K.T., et al., “meso Ionic Compounds. II. Derivatives of the s-Triazole Series,”The Journal of Organic Chemistry, 32(7): 2245-2252 (1967).
El-Sharief, A.M., et al., “Utility of Cyanothioformamides in Synthesis of Some Bis(Imidazole, Oxazole, Thiazole, Oxadiazole, Triazole, Benzoxazinethione and Quinazoline) Derivatives,”J. Chem. Research(S): 162-167 (2003).
Sawhney, et al., “Synthesis of Some 2-(5-Substituted 1,3,4-Oxadiazol-2-Yl)-, 2-(5-Substituted 1,3,4-Thiadiazol-2-Yl)- and 2-(3-Mercapto-4-Substituted-4H-1,2,4-Triazol-5-Yl)-Benzimidazoles as Potential Anti-Inflammatory Agents,”Indian J. of Chem., 30B: 407-412 (1991).
Tehranchian, S. et al., “Synthesis and antibacterial activity of 1-[1, 2, 4-triazol-3-yl] and 1-[1, 3, 4-thiadiazol-2-yl]-3-methylthio-6, 7-dihydrobenzo[c]thiophen-4(5H)ones,”Bioorganic&Medicinal Chemistry Letters, 15: 1023-1025 (2005).
Soni, N., et al., “Analgesic Activity and Monoamine Oxidase Inhibitory Property of Substituted Mercapto 1,2,4-Triazoles,”Eur. J. Med. Chem., 20(2): 190-192 (1985).
Sonar, et al., “Synthesis and Antimicrobial Activity of Triazolylindoles and Indolylthiazolidinones,”Indian J. of Heterocyclic Chem., 5: 269-272 (1996).
Russo, et al., “Derivati Benzotiazolici del 1,2,4-triazolo,”Annali di Chimica, 62: 351-372 (1972).
Romine, Jeffrey, L., et al., “4,5-Diphenyltriazol-3-ones: Openers of Large-Conductance Ca2+-Activated Potassium (Maxi-K) Channels,”J. Med. Chem., 45: 2942-2952 (2002).
Ramazani, A. et al., “Crystal structure of 4-[4-(dimethylamino)phenyl]-5-(2, 4-dimethyl-1, 3-thiazol-5-yl)-2, 4-dihydro-3H-1, 2, 4-triazol-3-thione, C15H17N5S2,”K. Kristallogr, NCS, 217:149-150 (2002).
Modzelewska-Banachiewicz, B., et al., “Synthesis and Biological Activity of BIS-1, 2, 4-Triazole and BIS-1, 3, 4-Thiadiazole Derivatives,”Acta Poloniac Pharmaceutica Drug Research, 57(3): 199-204 (2000).
Modzelewska, B., and Maliszewska, A., “The Reaction of N3-substituted Amidrazones with the Aromatic Izothiocyanates, Part III,” vol. XXXIXIXL, 13: 163-170 (1985).
Modzelewska, B., “Cyclization Reaction of Thiosemicarbazone-4-Picolinamide Derivatives,”Acta Poloniac Pharmaceutica-Drug Research, 52(5): 425-427 (1995).
Milcent, R., and Vicart, P., “Synthèse Et ActivitèAntibactèrienne D 'amino-4 Triazol-1,2,4 Ones-5 Substituèes,” Eur. J. Med. Chem.—Chim. Ther., 18(3): 215-220 (1983).
Ikizler, A., et al., “Synthesis of some New N,N′-Linked Biheteroaryls,”Polish Journal of Chemistry, 69:1497-1502 (1995).
Ikizler, A., et al., “Biological Activities of Some 1,2,4-triazoles and 1,2,4-triazolin-5-ones,”Die Pharmazie, 44(7): 506-507 (1989).
Ikizler, A., and Un, R., “Reactions of Ester Ethoxycarbonylhydrazones With Some Amine Type Compounds,”Chimica Acta Turcica, 7: 269-290 (1979).
Husain, S., et al., “3,4-Distributed 5-Hydroxy-1,2,4-triazoles Derived from 4-Substituted Semicarbazones,”Indian Journal of Chemistry, 9: 642-646 (1971).
Ciugureanu, C., and Ungureanu, M., “Synthesis of Novel 1,2,4-Triazoles and 1,3,4-Thiadiazoles Derivatives of 1,3-Benzoxazole,”Analele ÿtintifice Ale Universitaÿii, 5:151-158 (1997).
Cansiz, A., et al., “Synthesis of Some New 4,5-Substituted-4H-1,2,4-triazole-3-thiol Derivatives,” Molecules, 9: 204-212 (2004).
Ayca, E. et al., “Mass Spectra of Some 3,4-Disubstituted-ÿ2-1,2,4-Triazolin-5-Ones,”Chimica Acta Turcica,

Affiliated with

Also associated with

Rating

Triazole compounds that modulate Hsp90 activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Triazole compounds that modulate Hsp90 activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazole compounds that modulate Hsp90 activity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4275943